Form 4: M33 Growth Entities Adjust TOI Holdings via Distributions
Beneficial Ownership Change
M33 Growth I L.P. and related entities reported in-kind distributions of Oncology Institute common stock, altering their beneficial ownership.
Summary
- On November 18, 2025, TOI M, LLC distributed 590,892 shares of Oncology Institute, Inc. (TOI) common stock to its members.
- As part of this distribution, M33 Growth I L.P. (M33 LP) received 11,818 shares of TOI common stock.
- Also on November 18, 2025, M33 LP made a further distribution in-kind of 2,500,000 shares of TOI common stock to its limited partners.
- Following these transactions, TOI M, LLC's beneficial ownership of TOI common stock became 0 shares.
- M33 Growth I L.P.'s beneficial ownership of TOI common stock after these transactions is 5,444,207 shares.
- M33 Growth I GP LLC, as the general partner of M33 LP, may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership except to the extent of its pecuniary interest.
Sentiment
Score: 5
Explanation: The filing is a routine report of changes in beneficial ownership due to in-kind distributions among related entities, which is neutral in sentiment for the issuer, Oncology Institute, Inc.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Oncology Institute, Inc.'s future performance or operations.
Industry Context
This Form 4 filing primarily details internal ownership restructuring among investment entities related to M33 Growth and does not provide information directly related to broader industry trends or competitive landscape for Oncology Institute, Inc.
Related Party Transactions
- TOI M, LLC made an in-kind distribution of 590,892 shares of TOI common stock to its members, including M33 Growth I L.P.
- M33 Growth I L.P. subsequently made an in-kind distribution of 2,500,000 shares of TOI common stock to its limited partners.
Stakeholder Impact
- Shareholders of Oncology Institute, Inc. may observe a shift in the concentration of shares held by M33 Growth-related entities, but no direct operational or financial impact on the company is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 11/18/2025 | Date of in-kind stock distributions by TOI M, LLC and M33 Growth I L.P. |
| 11/20/2025 | Date the Form 4 filing was signed by Gabriel Ling, Managing Member of M33 Growth I GP LLC and TOI M, LLC. |
Keywords
Oncology Institute, TOI, M33 Growth, Form 4, Beneficial Ownership, Stock Distribution, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.